Efficacy of Probaclac in Irritable Bowel Syndrome in Children Aged 8 to 18 Years
Launched by ST. JUSTINE'S HOSPITAL · Nov 18, 2008
Trial Information
Current as of July 22, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children 8 to 18 years
- • Irritable bowel syndrome according to Rome III criteria
- Exclusion Criteria:
- • Not able to collaborate
- • Known Digestive malformation
- • History of digestive surgery (except hernia repair and appendectomy)
- • History of known digestive disease (Crohn's, ulcerative colitis, esophagitis, peptic ulcer, celiac disease)
- • Symptoms suggestive of organic disease (such as rectal bleeding, weight loss
- • History of chronic extra-digestive disease
- • Acute gastroenteritis in th e4 weeks prior to inclusion
- • Central catheter, artificial cardiac valve, endocardiac prothesis
- • Current Antidepressant treatment
- • Patients taking a treatment for irritable bowel syndrome unable to cease their current treatment
- • Patient taking regularly probiotics and natural products
About St. Justine's Hospital
St. Justine's Hospital is a leading pediatric healthcare institution dedicated to advancing child health through innovative clinical research. Renowned for its commitment to excellence in patient care and medical education, the hospital serves as a vital center for clinical trials aimed at improving therapeutic options for children. With a multidisciplinary team of experts, St. Justine's Hospital leverages cutting-edge technology and evidence-based practices to facilitate groundbreaking studies that address a wide range of pediatric conditions, ensuring the highest standards of safety and efficacy for its young patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montreal, Quebec, Canada
Patients applied
Trial Officials
Christophe M Faure, MD
Principal Investigator
Ste-Justine Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials